Case Study: AstraZeneca’s TAGRISSO boosts landing page views with Shuttlerock

Tagrisso - Customer Case Study

AstraZeneca’s TAGRISSO, a pharmaceutical treatment for EGFR+ lung cancer, needed a stronger digital campaign to expand reach and drive more traffic to its website. Although the brand had run mobile ads before, this was the first effort built with an Instagram-first approach, and AstraZeneca turned to Shuttlerock to create mobile-first creative assets optimized for that platform.

Working with AstraZeneca’s agencies, Shuttlerock transformed existing static assets into thumb-stopping video ads tailored for Instagram feed and story placements, using simple messaging, subtle animation, and clear calls to action while staying within pharmaceutical legal requirements. The campaign delivered a 200% increase in landing page view rate, a 67% decrease in cost per landing page view, and a 62% increase in qualified view rate, with AstraZeneca noting that optimized creative and placement best practices had a major impact on performance.

Tagrisso

Gus Strominger

Senior Marketing Manager